Home / Inspections / 1187482

FDA Inspection 1187482 — Delaware Institute for Reproductive Medicine, P.A

Delaware Institute for Reproductive Medicine, P.A — FEI 3003939643

The FDA completed an inspection of Delaware Institute for Reproductive Medicine, P.A on October 26, 2022 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 26, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Newark, DE (United States)

Facility

Other inspections at this facility

  • 1293390 (NAI Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1094217 (VAI Thu Jun 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1018967 (NAI Thu Jun 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 925928 (NAI Wed May 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 831892 (NAI Thu May 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources